Randox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
Randox Laboratories is recalling Liquid Cardiac Controls (CQ5053) to remove N-proBNP claims due to decreased recovery in recent lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a temporary or medically reversible adverse health consequence. The issue is a performance deviation (decreased recovery) leading to claim removal, without reported injuries or illnesses.
Plain-English summary
Randox Laboratories, Limited is recalling Randox Liquid Cardiac Controls, Catalogue Number CQ5053. The recall involves 6,702 units distributed in the United States (WV, CA, DE, NJ, NY, GA, IN, PR) and internationally. The affected lots are 4245CK, 4248CK, 4313CK, and 4316CK.
The recall is being conducted to remove claims for N-proBNP from the product. This action is due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots. The agency has classified this as a Class II recall.
Users of these products should stop using the affected lots and contact Randox Laboratories for further instructions or a replacement.
The recalled product
- Product
- Randox Liquid Cardiac Controls Catalogue Numbers CQ5053.
- Manufacturer
- Randox Laboratories, Limited
- Affected units
- 6,702
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 4248CK (Exp. 28Nov2019)
- 4313CK (Exp. 28Jun2020) and 4316CK (Exp. 28Jun2020)
Distribution
Part of a larger recall action
This product is one of 3 recalled by Randox Laboratories, Limited under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Randox Laboratories, Limited
See all →- HighRandox Lipoprotein (a) Diagnostic Assay Lacks FDA Clearance, Recalled
FDA (Devices) · 2025-01-29
- HighRandox Lipoprotein (a) assay distributed without required FDA clearance
FDA (Devices) · 2025-01-29
- ModerateRandox RX Daytona Plus Clinical Chemistry Analyzer Software Recall
FDA (Devices) · 2020-03-04
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02